You are here:HomeFor CliniciansPublished ResearchEffect on Clinical Outcomes
For Patients
What is PT/INR Self Testing?
How Self Testing Works
Benefits of Self Testing
Is Self Testing for You?
INR Meters
What People Say
Medications & Diet
Frequently Asked Questions
Get Started Now
For Clinicians
Improving Outcomes
How Self Testing Works
Which Patients Qualify
What Doctors Say
About the Meters
Frequently Asked Questions
Prescription - Rx
Clinician Info Kit
Published Research
Effect on Clinical Outcomes
Reduced Hospitalizations
The Home INR Study
Self Monitoring Meta-Analysis
Time in Therapeutic Range (TTR)
Heart Valve Replacement
Lowered Risk
Practical Implementation

About Us

Effect of Patient Self-testing and Self-management of Long-Term Anticoagulation on Major Clinical Outcomes

Annals of Internal Medicine 2011;154:472-482.

Hanna E. Bloomfield, MD, MPH; Ange Krause, MD; Nancy Greer, PhD; Brent C. Taylor, PhD, MPH; Roderick MacDonald, MS;

Indulis Rutks, BS; Preetham Reddy, MD; and Timothy J. Wilt, MD, MPH


Background: Anticoagulation with vitamin K antagonists reduces major thromboembolic complications in at-risk patients. With portable monitoring devices, patients can conduct their own international normalized ratio testing and dose adjustment at home.

Purpose: To determine whether patient self-testing (PST), alone or in combination with self-adjustment of doses (patient self management [PSM]), is associated with a reduction in thromboembolic complications and all-cause mortality without an increase in major bleeding events compared with usual care.


Conclusion: Compared with usual care, PST with or without PSM is associated with significantly fewer deaths and thromboembolic events, without increased risk for a serious bleeding event, for a highly selected group of motivated adult patients requiring long-term anticoagulation with vitamin K antagonists.









 Next Study >>